Fairfield, Bush & Co’s Iovance Biotherapeutics IOVA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-14,575	Closed	-$137K	–	116
2024 Q3	$137K	Sell	14,575 -6,650	-31%	-$62.4K	0.08%	110
2024 Q2	$170K	Sell	21,225 -225	-1%	-$1.81K	0.1%	110
2024 Q1	$318K	Buy	21,450 +21,330	+17,775%	+$316K	0.19%	92
2023 Q4	$976	Buy	+120	New	+$976	﹤0.01%	437